On 26th January 2017, I attended a back bench business debate in Parliament about the provisional decision not to provide the breast cancer drug Kadcyla for use in the NHS. The debate called for the National Institute for Health and Care Excellence (NICE) and pharmaceutical company Roche to re-assess the […]
Read MorePost Tagged with: "Cancer"
Cancer Prevalence in the UK 2010 – 2040
In the course of reading ResPublica’s report Power to the People: The mutual future of our National Health Service, I found this horrific chart: The section explaining “Why the NHS is on an unsustainable footing” clearly discusses pressures on the NHS from obesity, diabetes, cardiovascular disease, cancer, arthritis, dementia and depression. […]
Read More
